JO
HSCS icon

John Overdeck’s Heart Test Laboratories HSCS Stock Holding History

John Overdeck’s Portfolio HSCS Stock Details HSCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-153
Closed -$15.1K – 3119
2023
Q1 		$15.1K Buy
+153
New +$20.7K ﹤0.01% 2869

Other funds holding HSCS

TWM
Tradition Wealth Management Edina, Minnesota $1.64B AUM 26.59% 1-Year Est. Return
OLVIG
Oliver Lagore Vanvalin Investment Group Flint, Michigan $255M AUM
AWM
AE Wealth Management Topeka, Kansas $21.5B AUM 26.98% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
CD
Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ASW
Astoria Strategic Wealth Conroe, Texas $438M AUM 16.79% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

John Overdeck's HSCS Position: Q2 2023 in Review

John Overdeck sold out of Heart Test Laboratories (HSCS) in Q2 2023, closing a stake of 153 shares — an estimated $15.1K sold.

John Overdeck first reported a position in HSCS in Q1 2023 and held it in 1 quarter. The position peaked at $15.1K in Q1 2023. 10 funds tracked by Wall St. Rank hold HSCS as of Q2 2023.

  • John Overdeck reported no remaining Heart Test Laboratories position as of Q2 2023 after selling out during the quarter.
  • John Overdeck sold 153 Heart Test Laboratories shares in Q2 2023, an estimated $15.1K.
  • John Overdeck first reported a position in Heart Test Laboratories in Q1 2023 and held it in 1 quarter.
  • John Overdeck's Heart Test Laboratories position peaked at $15.1K in Q1 2023.
  • 10 funds tracked by Wall St. Rank held Heart Test Laboratories as of Q2 2023.

Based on Two Sigma Investments's 13F filing for Q2 2023, filed 14 Aug 2023.